Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2015

01.07.2015 | Article

Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics

verfasst von: T. Suwabe, H. Araoka, Y. Ubara, K. Kikuchi, R. Hazue, K. Mise, S. Hamanoue, T. Ueno, K. Sumida, N. Hayami, J. Hoshino, A. Imafuku, M. Kawada, R. Hiramatsu, E. Hasegawa, N. Sawa, K. Takaichi

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Cyst infection is a frequent and serious complication of autosomal dominant polycystic kidney disease (ADPKD). Lipid-soluble antibiotics like fluoroquinolones show good penetration into cysts and are recommended for cyst infection, but causative microorganisms are often resistant to these agents. This study investigated the profile of the microorganisms causing cyst infection in ADPKD, their susceptibility to lipid-soluble antibiotics, and clinical outcomes. This retrospective study reviewed all ADPKD patients admitted to Toranomon Hospital with a diagnosis of cyst infection from January 2004 to March 2014. All patients who underwent cyst drainage and had positive cyst fluid cultures were enrolled. Patients with positive blood cultures who satisfied our criteria for cyst infection or probable infection were also enrolled. There were 99 episodes with positive cyst fluid cultures and 93 episodes with positive blood cultures. The majority of patients were on dialysis. The death rate was high when infection was caused by multiple microorganisms or when there were multiple infected cysts. Gram-negative bacteria accounted for 74–79 % of the isolates in all groups, except for patients with positive hepatic cyst fluid cultures. The susceptibility of Escherichia coli to fluoroquinolones was very low in patients with hepatic cyst infection, especially those with frequent episodes and those with hepatomegaly. Fungi were detected in two episodes. Fluoroquinolone-resistant microorganisms showed a high prevalence in cyst infection. It is important to identify causative microorganisms to avoid the overuse of fluoroquinolones and to improve the outcome of cyst infection in ADPKD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Torres VE (2001) Polycystic kidney disease autosomal-dominant and recessive forms. In: Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 896–904 Torres VE (2001) Polycystic kidney disease autosomal-dominant and recessive forms. In: Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 896–904
2.
Zurück zum Zitat Gardner KD Jr, Evan AP (1984) Cystic kidneys: an enigma evolves. Am J Kidney Dis 3(6):403–413PubMedCrossRef Gardner KD Jr, Evan AP (1984) Cystic kidneys: an enigma evolves. Am J Kidney Dis 3(6):403–413PubMedCrossRef
3.
Zurück zum Zitat Schwab SJ, Bander SJ, Klahr S (1987) Renal infection in autosomal dominant polycystic kidney disease. Am J Med 82(4):714–718PubMedCrossRef Schwab SJ, Bander SJ, Klahr S (1987) Renal infection in autosomal dominant polycystic kidney disease. Am J Med 82(4):714–718PubMedCrossRef
4.
Zurück zum Zitat Chapman AB, Thickman D, Gabow PA (1990) Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 16(3):252–255PubMedCrossRef Chapman AB, Thickman D, Gabow PA (1990) Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 16(3):252–255PubMedCrossRef
6.
Zurück zum Zitat Suwabe T, Ubara Y, Sumida K, Hayami N, Hiramatsu R, Yamanouchi M, Hasegawa E, Hoshino J, Sawa N, Saitoh S, Okuda I, Takaichi K (2012) Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria. Clin Exp Nephrol 16(6):892–902PubMedCrossRef Suwabe T, Ubara Y, Sumida K, Hayami N, Hiramatsu R, Yamanouchi M, Hasegawa E, Hoshino J, Sawa N, Saitoh S, Okuda I, Takaichi K (2012) Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria. Clin Exp Nephrol 16(6):892–902PubMedCrossRef
7.
Zurück zum Zitat Muther RS, Bennett WM (1981) Cyst fluid antibiotic concentrations in polycystic kidney disease: differences between proximal and distal cysts. Kidney Int 20(4):519–522PubMedCrossRef Muther RS, Bennett WM (1981) Cyst fluid antibiotic concentrations in polycystic kidney disease: differences between proximal and distal cysts. Kidney Int 20(4):519–522PubMedCrossRef
8.
Zurück zum Zitat Bennett WM, Elzinga L, Pulliam JP, Rashad AL, Barry JM (1985) Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis 6(6):400–404PubMedCrossRef Bennett WM, Elzinga L, Pulliam JP, Rashad AL, Barry JM (1985) Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis 6(6):400–404PubMedCrossRef
9.
Zurück zum Zitat Schwab S, Hinthorn D, Diederich D, Cuppage F, Grantham J (1983) pH-dependent accumulation of clindamycin in a polycystic kidney. Am J Kidney Dis 3(1):63–66PubMedCrossRef Schwab S, Hinthorn D, Diederich D, Cuppage F, Grantham J (1983) pH-dependent accumulation of clindamycin in a polycystic kidney. Am J Kidney Dis 3(1):63–66PubMedCrossRef
10.
Zurück zum Zitat Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM (1987) Trimethoprim–sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int 32(6):884–888PubMedCrossRef Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM (1987) Trimethoprim–sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int 32(6):884–888PubMedCrossRef
11.
Zurück zum Zitat Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM (1988) Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother 32(6):844–847PubMedCentralPubMedCrossRef Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM (1988) Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother 32(6):844–847PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Rossi SJ, Healy DP, Savani DV, Deepe G (1993) High-dose ciprofloxacin in the treatment of a renal cyst infection. Ann Pharmacother 27(1):38–39PubMed Rossi SJ, Healy DP, Savani DV, Deepe G (1993) High-dose ciprofloxacin in the treatment of a renal cyst infection. Ann Pharmacother 27(1):38–39PubMed
13.
Zurück zum Zitat Hiyama L, Tang A, Miller LG (2006) Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Am J Kidney Dis 47(1):e9–e13PubMedCrossRef Hiyama L, Tang A, Miller LG (2006) Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Am J Kidney Dis 47(1):e9–e13PubMedCrossRef
14.
Zurück zum Zitat Schwab SJ, Weaver ME (1986) Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. Am J Kidney Dis 7(5):434–438PubMedCrossRef Schwab SJ, Weaver ME (1986) Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. Am J Kidney Dis 7(5):434–438PubMedCrossRef
15.
Zurück zum Zitat Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, Nishimura H, Hoshino J, Sawa N, Katori H, Takemoto F, Nakamura M, Tomikawa S, Hara S, Takaichi K (2009) Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Pract 112(3):c157–c163PubMedCrossRef Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, Nishimura H, Hoshino J, Sawa N, Katori H, Takemoto F, Nakamura M, Tomikawa S, Hara S, Takaichi K (2009) Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Pract 112(3):c157–c163PubMedCrossRef
16.
Zurück zum Zitat Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F (2009) Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4(7):1183–1189PubMedCentralPubMedCrossRef Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F (2009) Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4(7):1183–1189PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, Kanaan N (2012) Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant 27(10):3746–3751PubMedCrossRef Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, Kanaan N (2012) Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant 27(10):3746–3751PubMedCrossRef
18.
Zurück zum Zitat Truven Health Analytics, Inc. (2014) Dosing information: dosage in renal failure. DRUGDEX® Truven Health Analytics, Inc. (2014) Dosing information: dosage in renal failure. DRUGDEX®
19.
Zurück zum Zitat Jouret F, Lhommel R, Beguin C, Devuyst O, Pirson Y, Hassoun Z, Kanaan N (2011) Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6(7):1644–1650PubMedCrossRef Jouret F, Lhommel R, Beguin C, Devuyst O, Pirson Y, Hassoun Z, Kanaan N (2011) Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6(7):1644–1650PubMedCrossRef
20.
Zurück zum Zitat Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, Huang CC, Liu CE, Ko WC, Wang JH, Tang HJ, Yu KW, Chen YS, Chuang YC, Xu Y, Ni Y, Chen YH, Hsueh PR (2012) Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 40(Suppl):S37–S43PubMedCrossRef Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, Huang CC, Liu CE, Ko WC, Wang JH, Tang HJ, Yu KW, Chen YS, Chuang YC, Xu Y, Ni Y, Chen YH, Hsueh PR (2012) Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 40(Suppl):S37–S43PubMedCrossRef
21.
Zurück zum Zitat Fissell RB, Fuller DS, Morgenstern H, Gillespie BW, Mendelssohn DC, Rayner HC, Robinson BM, Schatell D, Kawanishi H, Pisoni RL (2013) Hemodialysis patient preference for type of vascular access: variation and predictors across countries in the DOPPS. J Vasc Access 14(3):264–272PubMedCrossRef Fissell RB, Fuller DS, Morgenstern H, Gillespie BW, Mendelssohn DC, Rayner HC, Robinson BM, Schatell D, Kawanishi H, Pisoni RL (2013) Hemodialysis patient preference for type of vascular access: variation and predictors across countries in the DOPPS. J Vasc Access 14(3):264–272PubMedCrossRef
22.
Zurück zum Zitat Ravani P, Gillespie BW, Quinn RR, MacRae J, Manns B, Mendelssohn D, Tonelli M, Hemmelgarn B, James M, Pannu N, Robinson BM, Zhang X, Pisoni R (2013) Temporal risk profile for infectious and noninfectious complications of hemodialysis access. J Am Soc Nephrol 24(10):1668–1677PubMedCentralPubMedCrossRef Ravani P, Gillespie BW, Quinn RR, MacRae J, Manns B, Mendelssohn D, Tonelli M, Hemmelgarn B, James M, Pannu N, Robinson BM, Zhang X, Pisoni R (2013) Temporal risk profile for infectious and noninfectious complications of hemodialysis access. J Am Soc Nephrol 24(10):1668–1677PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, Tanaka K, Kiyota H, Muratani T, Monden K, Arakawa S, Yamamoto S (2011) Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Int J Antimicrob Agents 37(3):210–218PubMedCrossRef Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, Tanaka K, Kiyota H, Muratani T, Monden K, Arakawa S, Yamamoto S (2011) Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Int J Antimicrob Agents 37(3):210–218PubMedCrossRef
24.
Zurück zum Zitat Chapman AB, Rahbari-Oskoui FF, Bennett WM (2014) Urinary tract infection in autosomal dominant polycystic kidney disease. UpToDate®. Last Updated 3 Dec. 2014 Chapman AB, Rahbari-Oskoui FF, Bennett WM (2014) Urinary tract infection in autosomal dominant polycystic kidney disease. UpToDate®. Last Updated 3 Dec. 2014
Metadaten
Titel
Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics
verfasst von
T. Suwabe
H. Araoka
Y. Ubara
K. Kikuchi
R. Hazue
K. Mise
S. Hamanoue
T. Ueno
K. Sumida
N. Hayami
J. Hoshino
A. Imafuku
M. Kawada
R. Hiramatsu
E. Hasegawa
N. Sawa
K. Takaichi
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2015
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2361-6

Weitere Artikel der Ausgabe 7/2015

European Journal of Clinical Microbiology & Infectious Diseases 7/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.